An integrated prediction model of recurrence in endometrial endometrioid cancers

References

• SEER Cancer Stat Facts: Endometrial Cancer. Bethesda, MD: National Cancer Institute Available from: http://seer.cancer.gov/statfacts/html/corp.html. Accessed May 10, 2019.
   Google Scholar
• Endometrial Cancer Treatment (PDQ®) – Health Professional Version. Bethesda, MD: National Cancer Institute Available from: https://www.cancer.gov/types/uterine/hp/endometrial-treatment-pdq#section/_9. Accessed May 10, 2019.
   Google Scholar
• Sheikh MA, Althouse AD, Freese KE, et al. USA endometrial cancer projections to 2030: should we be concerned? Future Oncol. 2014;10(6):2561–2568. doi:10.2217/fon.14.19225531045
   PubMedGoogle Scholar
• Del Carmen MG, Boruta DM, Schorge JO. Recurrent endometrial cancer. Clin Obstet Gynecol. 2011;54(2):266–277. doi:10.1097/GRF.0b013e318218c6d121508696
   PubMed Web of Science ®Google Scholar
• Lee KR, Vacek PM, Belinson JL. Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma. Gynecol Oncol. 1994;54(1):10–18. doi:10.1006/gyno.1994.11588020830
   PubMed Web of Science ®Google Scholar
• Senol T, Polat M, Ozkaya E, Karateke A. Tumor diameter for prediction of recurrence, disease free and overall survival in endometrial cancer cases. Asian Pc J Cancer Prev. 2015;16(17):7463–7466. doi:10.7314/APJCP.2015.16.17.7463
   PubMedGoogle Scholar
• Versluis MA, de Jong RA, Plat A, et al. Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters. Br J Cancer. 2015;113(5):786–793. doi:10.1038/bjc.2015.26826217922
   PubMed Web of Science ®Google Scholar
• Kang SY, Cheon GJ, Lee M, et al. Prediction of recurrence by preoperative intratumoral FDG uptake heterogeneity in endometrioid endometrial cancer. Transl Oncol. 2017;10(2):178–183. doi:10.1016/j.tranon.2017.01.00228167243
   PubMed Web of Science ®Google Scholar
• Creutzberg CL, van Stiphout RG, Nout RA, et al. Nomograms for prediction of outcome with or without adjuvant radiation therapy for patients with endometrial cancer: a pooled analysis of PORTEC-1 and PORTEC-2 trials. Int J Radiat Oncol Biol Phys. 2015;91(3):530–539. doi:10.1016/j.ijrobp.2014.11.02225680597
   PubMed Web of Science ®Google Scholar
• Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer. 1987;60(8):2035–2041.3652025
   PubMed Web of Science ®Google Scholar
• Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol. 2004;92(3):744–751. doi:10.1016/j.ygyno.2003.11.04814984936
   PubMed Web of Science ®Google Scholar
• Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicenter randomized trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet. 2000;355(9213):1404–1411.3.10791524
   PubMed Web of Science ®Google Scholar
• Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–104.19367689
   PubMed Web of Science ®Google Scholar
• Dai D, Thiel KW, Salinas EA, Goodheart MJ, Leslie KK, Gonzalez Bosquet J. Preoperative stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations. Gynecol Oncol. 2016;142(1):150–157. doi:10.1016/j.ygyno.2016.05.01227181389
   PubMed Web of Science ®Google Scholar
• Schroeder A, Mueller O, Stocker S, et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006;7:3. doi:10.1186/1471-2199-7-316448564
   PubMed Web of Science ®Google Scholar
• Afgan E, Baker D, van Den Beek M, et al. The galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 2016;44:W3–W10. doi:10.1093/nar/gkw34327137889
   PubMed Web of Science ®Google Scholar
• Simon R, Lam A, Li MC, Ngan M, Menenzes S, Zhao Y. Analysis of gene expression data using BRB-ArrayTools. Cancer Inform. 2007;3:11–17. doi:10.1177/11769351070030002219455231
   PubMedGoogle Scholar
• Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14(4):R36. doi:10.1186/gb-2013-14-4-r3623618408
   PubMed Web of Science ®Google Scholar
• Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923–930. doi:10.1093/bioinformatics/btt65624227677
   PubMed Web of Science ®Google Scholar
• Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11(10):R106. doi:10.1186/gb-2010-11-11-r11020979621
   PubMed Web of Science ®Google Scholar
• Li H, Handsaker B, Wysoker A, et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25(16):2078–2079. doi:10.1093/bioinformatics/btp35219505943
   PubMed Web of Science ®Google Scholar
• Kuilman T, Velds A, Kemper K, et al. CopywriteR: DNA copy number detection from off-target sequence data. Genome Biol. 2015;16:49. doi:10.1186/s13059-015-0667-425887352
   PubMed Web of Science ®Google Scholar
• Kuhn M. Building predictive models in r using the caret package. J Stat Softw. 2008;28:1–26. doi:10.18637/jss.v028.i0727774042
   PubMed Web of Science ®Google Scholar
• Subramanian J, Simon R. Overfitting in prediction models – is it a problem only in high dimensions? Contemp Clin Trials. 2013;36:636–641. doi:10.1016/j.cct.2013.06.01123811117
   PubMed Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22.20808728
   PubMed Web of Science ®Google Scholar
• Simon R. Roadmap for developing and validating therapeutically relevant genomic classifiers. J Clin Oncol. 2005;23(29):7332–7341. doi:10.1200/JCO.2005.02.871216145063
   PubMed Web of Science ®Google Scholar
• R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2016 Available from: https://www.R-project.org/
   Google Scholar
• Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics. 2004;5(4):557–572. doi:10.1093/biostatistics/kxh00815475419
   PubMed Web of Science ®Google Scholar
• Beroukhim R, Getz G, Nghiemphu L, et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A. 2007;104(50):20007–20012. doi:10.1073/pnas.071005210418077431
   PubMed Web of Science ®Google Scholar
• Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. doi:10.1186/1471-2105-12-7721414208
   PubMed Web of Science ®Google Scholar
• Quick facts. United States Census Bureau Quick Facts: Iowa, U. S. Department of Commerce Available from: https://www.census.gov/quickfacts/IA. Accessed May 10, 2019`.
   Google Scholar
• Zhao WG, Yu SN, Lu ZH, Ma YH, Gu YM, Chen J. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis. 2010;31(10):1726–1733. doi:10.1093/carcin/bgq16020675343
   PubMed Web of Science ®Google Scholar
• Chen D-L, Zhang D-S, Lu Y-X, et al. microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer. Oncotarget. 2015;6(13):10868–10879. doi:10.18632/oncotarget.345125869101
   PubMedGoogle Scholar
• Zhang X, Zhang X, Liu C, Jia N, Li X, Xiao J. miR-224 promotes colorectal cancer cells proliferation via downregulation of P21WAF1/CIP1. Mol Med Rep. 2014;9(3):941–946. doi:10.3892/mmr.2014.190024430932
   PubMed Web of Science ®Google Scholar
• Cui R, Kim T, Fassan M, et al. MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. Oncotarget. 2015;6(26):21802–21815. doi:10.18632/oncotarget.522426307684
   PubMedGoogle Scholar
• Goto Y, Nishikawa R, Kojima S, et al. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer. FEBS Lett. 2014;588(10):1973–1982. doi:10.1016/j.febslet.2014.04.02024768995
   PubMed Web of Science ®Google Scholar
• Basu M, Khan MW, Chakrabarti P, Das C. Chromatin reader ZMYND8 is a key target of all trans retinoic acid-mediated inhibition of cancer cell proliferation. Biochim Biophys Acta. 2017;1860(4):450–459. doi:10.1016/j.bbagrm.2017.02.004
   Web of Science ®Google Scholar
• Li N, Li Y, Lv J, et al. ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes. Mol Cell. 2017;63(3):470–484. doi:10.1016/j.molcel.2016.06.035
   Web of Science ®Google Scholar
• Den Uil SH, Coupé VM, Linnekamp JF, et al. Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence. Br J Cancer. 2016;115(12):1565–1574. doi:10.1038/bjc.2016.37627855440
   PubMed Web of Science ®Google Scholar
• Dozier C, Mazzolini L, Cénac C, et al. CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability. Oncogene. 2017;36(26):3781–3788. doi:10.1038/onc.2016.50628192398
   PubMed Web of Science ®Google Scholar
• Kalinina EV, Berozov TT, Shtil AA, et al. Expression of genes of glutathione transferase isoforms GSTP1-1, GSTA4-4, and GSTK1-1 in tumor cells during the formation of drug resistance to cisplatin. Bull Exp Biol Med. 2012;154(1):64–67.23330092
   PubMed Web of Science ®Google Scholar
• Cowden Dahl KD, Dahl R, Kruichak JN, Hudson LG. The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia. 2009;11(11):1208–1215.19881956
   PubMed Web of Science ®Google Scholar